Tuesday, January 26, 2021
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Times Asian
  • Home
    • Opinion
      • Crime
        • Latest News
  • South Asia
    • India
    • Pakistan
    • Bangladesh
      • Bhutan
        • Srilanka
    • Nepal
    • Maldives
  • Economics
    • Investment
      • Market
        • Insurance
  • Banking
    • Share
  • Lifestyle
    • Tourism
      • Entertainment
        • Gossip
          • Film
        • Music
    • Agriculture
      • Bollywood
  • Sports
  • Education
  • Newspaper
    • International
  • Other
    • Science
      • Politics
    • Interesting news
      • Literature
  • Home
    • Opinion
      • Crime
        • Latest News
  • South Asia
    • India
    • Pakistan
    • Bangladesh
      • Bhutan
        • Srilanka
    • Nepal
    • Maldives
  • Economics
    • Investment
      • Market
        • Insurance
  • Banking
    • Share
  • Lifestyle
    • Tourism
      • Entertainment
        • Gossip
          • Film
        • Music
    • Agriculture
      • Bollywood
  • Sports
  • Education
  • Newspaper
    • International
  • Other
    • Science
      • Politics
    • Interesting news
      • Literature
Times Asian
No Result
View All Result

Serum Institute and Bharat Biotech to begin trial of intranasal COVID-19 vaccine

India’s Dr Reddy’s Laboratories Ltd and the Russian Direct Investment Fund (RDIF) said they have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine

October 20, 2020
in Economics, Latest News, Politics
0
31
SHARES
56
VIEWS
Share on FacebookShare on Twitter

New Delhi. Serum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal COVID-19 vaccines in the coming months once they receive regulatory approval, Health Minister Dr Harsh Vardhan said on Sunday.

Vardhan said the late stage trial generally involves thousands of participants, sometimes 30,000 to 40,000.

Of the vaccines currently in Phase 3 trials, all are administered by injection, according to the World Health Organization (WHO).

On Saturday, India’s Dr Reddy’s Laboratories Ltd and the Russian Direct Investment Fund (RDIF) said they have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine.

India’s coronavirus infections rose by another 61,871 over the past 24 hours, data released on Sunday showed, although the health ministry said it is seeing a trend of steadily declining active cases.

The Indian Council of Medical Research (ICMR) said it will revisit its protocol for COVID-19 treatment after the WHO found some of the commonly used drugs, including remdesivir, had little or no impact on a patient’s chances of surviving, local media reported earlier on Sunday. – Reuters

 

Previous Post

New Zealand's Ardern to form government within 3 weeks

Next Post

China rapidly increases its experimental coronavirus vaccines

Times Asian

Times Asian

Next Post
China rapidly increases its experimental coronavirus vaccines

China rapidly increases its experimental coronavirus vaccines

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Meta

  • Register
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
 
                                                       
January 2021
S M T W T F S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
« Dec    

Times Asian

Times Asian is a latest and exclusive online news portal where you can easily access and read news around world, simply logging www.timesasian.com you can get news and views of expertise based on depth reports.

 

Categories

  • Bangladesh
  • Banking
  • Bollywood
  • Crime
  • Economics
  • Education
  • Entertainment
  • Film
  • Gossip
  • Highlights
  • India
  • Interesting News
  • International
  • Latest News
  • Lifestyle
  • Literature
  • Maldives
  • Music
  • Nepal
  • Newspaper
  • Opinion
  • Other
  • Politics
  • Science
  • South Asia
  • Sports
  • Srilanka
  • Tourism

Newsletter

Editor : Raju Lama                                                                      Email : timesasian.editor@gmail.com                              Website : www.timesasian.com

© timesasian 2020, All rights reserved. powered by sastosite.com

No Result
View All Result
  • Home
    • Opinion
      • Crime
  • South Asia
    • India
    • Pakistan
    • Bangladesh
      • Bhutan
    • Nepal
    • Maldives
  • Economics
    • Investment
      • Market
  • Banking
    • Share
  • Lifestyle
    • Tourism
      • Entertainment
    • Agriculture
      • Bollywood
  • Sports
  • Education
  • Newspaper
    • International
  • Other
    • Science
      • Politics
    • Interesting news
      • Literature